We are live on ! Find out more
CLLS icon

Cellectis

27 hedge funds and large institutions have $20.9M invested in Cellectis in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $13K | Put options by funds: $3K

0% more funds holding

Funds holding: 27 → 27 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

0.01% less ownership

Funds ownership: 9.76% → 9.76% (-0.01%)

13% less capital inflows, than outflows

Capital inflows: $92.5K | Capital outflows: $106K

Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
2
Calls
$13K
Puts
$3K
Net Calls
+$10K
Net Calls Change
+$35K

CLLS Hedge Fund Activity: Q3 2024 in Review

27 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2024, worth a combined $20.9M — up 14% from $18.3M a quarter earlier.

Fund positioning in CLLS was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 5 trimmed.

The largest buyer was First Affirmative Financial Network, opening a new position worth an estimated $45.8K. The largest seller was Principal Financial Group, cutting an estimated $54.7K.

  • 27 institutional investors held Cellectis (CLLS) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $20.9M of Cellectis stock for Q3 2024, up 14% quarter-over-quarter.
  • 2 funds opened new Cellectis positions in Q3 2024 and 2 closed out, a net change of 0 holders.
  • The largest Cellectis buyer in Q3 2024 was First Affirmative Financial Network, an estimated $45.8K added.
  • The largest Cellectis seller in Q3 2024 was Principal Financial Group, an estimated $54.7K sold.

Based on aggregated 13F filings for Q3 2024.